Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella

Conditions

• Rubella
• Measles

Interventions

• BIOLOGICAL: Double viral (MR) vaccine

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Collaborators

• [object Object]